|
|
Office Locations:
|
137a George Street
Edinburgh, EH2 4JY
UK
Phone: +44-131-243-3700
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Epidarex Capital is a venture capital firm that invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and US. The firm invests in all areas of health technology and life science including biotechnology, medical devices, pharmaceuticals, personalized medicine and diagnostics, as well as healthcare IT and services.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
